(Thanks to NoCamels.com) Julian Levy, CFO of Israel’s Vaxil Biotherapeutics speaks to NoCamels about Vaxil’s cancer vaccine, ImMucin, that boosts the immune system and prevents cancer returning.  ImMucin triggers a response in about 90 percent of all types of cancer.

http://nocamels.com/2015/01/new-vaccine-for-cancer/